Cargando…

Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition

Cell competition has recently emerged as an important tumor suppressor mechanism in the thymus that inhibits autonomous thymic maintenance. Here, we show that the oncogenic transcription factor Lmo2 causes autonomous thymic maintenance in transgenic mice by inhibiting early T cell differentiation. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Hesham D., Alserihi, Raed, Flensburg, Christoffer, Abeysekera, Waruni, Luo, Meng-Xiao, Gray, Daniel H.D., Liu, Xiaodong, Smyth, Gordon K., Alexander, Warren S., Majewski, Ian J., McCormack, Matthew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037042/
https://www.ncbi.nlm.nih.gov/pubmed/36920307
http://dx.doi.org/10.1084/jem.20212383
_version_ 1784911797735653376
author Abdulla, Hesham D.
Alserihi, Raed
Flensburg, Christoffer
Abeysekera, Waruni
Luo, Meng-Xiao
Gray, Daniel H.D.
Liu, Xiaodong
Smyth, Gordon K.
Alexander, Warren S.
Majewski, Ian J.
McCormack, Matthew P.
author_facet Abdulla, Hesham D.
Alserihi, Raed
Flensburg, Christoffer
Abeysekera, Waruni
Luo, Meng-Xiao
Gray, Daniel H.D.
Liu, Xiaodong
Smyth, Gordon K.
Alexander, Warren S.
Majewski, Ian J.
McCormack, Matthew P.
author_sort Abdulla, Hesham D.
collection PubMed
description Cell competition has recently emerged as an important tumor suppressor mechanism in the thymus that inhibits autonomous thymic maintenance. Here, we show that the oncogenic transcription factor Lmo2 causes autonomous thymic maintenance in transgenic mice by inhibiting early T cell differentiation. This autonomous thymic maintenance results in the development of self-renewing preleukemic stem cells (pre-LSCs) and subsequent leukemogenesis, both of which are profoundly inhibited by restoration of thymic competition or expression of the antiapoptotic factor BCL2. Genomic analyses revealed the presence of Notch1 mutations in pre-LSCs before subsequent loss of tumor suppressors promotes the transition to overt leukemogenesis. These studies demonstrate a critical role for impaired cell competition in the development of pre-LSCs in a transgenic mouse model of T cell acute lymphoblastic leukemia (T-ALL), implying that this process plays a role in the ontogeny of human T-ALL.
format Online
Article
Text
id pubmed-10037042
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-100370422023-09-15 Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition Abdulla, Hesham D. Alserihi, Raed Flensburg, Christoffer Abeysekera, Waruni Luo, Meng-Xiao Gray, Daniel H.D. Liu, Xiaodong Smyth, Gordon K. Alexander, Warren S. Majewski, Ian J. McCormack, Matthew P. J Exp Med Article Cell competition has recently emerged as an important tumor suppressor mechanism in the thymus that inhibits autonomous thymic maintenance. Here, we show that the oncogenic transcription factor Lmo2 causes autonomous thymic maintenance in transgenic mice by inhibiting early T cell differentiation. This autonomous thymic maintenance results in the development of self-renewing preleukemic stem cells (pre-LSCs) and subsequent leukemogenesis, both of which are profoundly inhibited by restoration of thymic competition or expression of the antiapoptotic factor BCL2. Genomic analyses revealed the presence of Notch1 mutations in pre-LSCs before subsequent loss of tumor suppressors promotes the transition to overt leukemogenesis. These studies demonstrate a critical role for impaired cell competition in the development of pre-LSCs in a transgenic mouse model of T cell acute lymphoblastic leukemia (T-ALL), implying that this process plays a role in the ontogeny of human T-ALL. Rockefeller University Press 2023-03-15 /pmc/articles/PMC10037042/ /pubmed/36920307 http://dx.doi.org/10.1084/jem.20212383 Text en © 2023 Abdulla et al. https://creativecommons.org/licenses/by-nc-sa/4.0/http://www.rupress.org/terms/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Abdulla, Hesham D.
Alserihi, Raed
Flensburg, Christoffer
Abeysekera, Waruni
Luo, Meng-Xiao
Gray, Daniel H.D.
Liu, Xiaodong
Smyth, Gordon K.
Alexander, Warren S.
Majewski, Ian J.
McCormack, Matthew P.
Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition
title Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition
title_full Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition
title_fullStr Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition
title_full_unstemmed Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition
title_short Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition
title_sort overexpression of lmo2 initiates t-lymphoblastic leukemia via impaired thymocyte competition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037042/
https://www.ncbi.nlm.nih.gov/pubmed/36920307
http://dx.doi.org/10.1084/jem.20212383
work_keys_str_mv AT abdullaheshamd overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition
AT alserihiraed overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition
AT flensburgchristoffer overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition
AT abeysekerawaruni overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition
AT luomengxiao overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition
AT graydanielhd overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition
AT liuxiaodong overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition
AT smythgordonk overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition
AT alexanderwarrens overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition
AT majewskiianj overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition
AT mccormackmatthewp overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition